Quantcast

Latest astrocytoma Stories

2010-01-14 12:11:31

Missing, mutated genes occur simultaneously in unique set of pediatric brain tumors Brain cancer is the leading cause of cancer death in children. Now a more accurate diagnosis of childhood brain cancers may soon be possible, according to researchers at Huntsman Cancer Institute (HCI) at the University of Utah. The information is published online today in the journal Cancer Research. "Researchers already know cancerous tumors often lack certain copies of genes. They also know certain...

2009-12-04 13:27:56

There was no substantial change in brain tumor incidence among adults 5 to 10 years after cell phone usage sharply increased, according to a new brief communication published online December 3 in the Journal of the National Cancer Institute. Although cell phone use has been proposed as a risk factor for brain tumors, a biological mechanism to explain this association is not known. Isabelle Deltour, Ph.D., of the Institute of Cancer Epidemiology, Danish Cancer Society, in Copenhagen, and...

2009-12-02 08:30:00

TUSTIN, Calif., Dec. 2 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with relapsed glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara is a targeted monoclonal antibody linked to a radioisotope being developed as a potential new treatment for GBM. Cotara specifically targets cells at the center of brain...

2009-09-02 06:30:00

BOSTON, Mass. and TUSTIN, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported that clinical investigators are presenting interim Phase II data showing that its brain cancer agent Cotara(R) appeared well tolerated and demonstrated encouraging signs of efficacy in patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. The data from an ongoing Phase II study of Cotara in patients with recurrent GBM is being...

2009-09-01 10:53:38

Malignant brain tumors often fail to respond to promising new medication. Researchers in Heidelberg have discovered a mechanism and a tumor marker for the development of this resistance. A "death receptor" can possibly provide information as to how great the chances of success are for chemotherapy. At the same time, it offers a new approach for promising brain tumor therapy. Dr. Wolf Mller, senior consultant in the Neuropathology Department at the Institute of Pathology of Heidelberg...

687ad8980cd17d568f9caa78b711b7761
2009-07-14 13:10:00

A new technology involving the fusion of four different types of images into a 3-D map of a patient's brain has helped University of Cincinnati (UC) specialists successfully remove a fist-sized tumor from the brain of an Indiana woman. The surgery was performed at University Hospital by an eight-member team from the Brain Tumor Center at the UC Neuroscience Institute. "This marks the culmination of one of the most important developments in brain tumor surgery in the last 100 years,"...

2009-06-16 11:30:00

- Dosimetry Study Results Show Greater Than 300-Fold More Radiation Delivered to Tumor as Compared to Other Normal Organs - - All Patients in the First Two Cohorts Have Met or Exceeded the Expected Median Survival Time for Recurrent GBM Patients - TORONTO and TUSTIN, Calif., June 16 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today reported that researchers will present data at the SNM 2009 Annual Meeting showing that its brain cancer agent Cotara(R)...

2009-06-01 21:59:00

Drummer for 'Loose Chains' joins researchers, physicians, neurosurgeons and other brain tumor survivors June 13 at Cedars-Sinai Medical Center LOS ANGELES, June 1 /PRNewswire/ -- It is not uncommon for musicians to have to work around scheduling conflicts, but Eddie Cleland, drummer for "Loose Chains" and two other bands, had to adjust his calendar to accommodate brain tumor surgery, which was performed by Keith Black, M.D., chairman of the Department of Neurosurgery at Cedars-Sinai Medical...

2009-05-28 06:59:00

--Data from Ongoing Glioblastoma Dosimetry Trial Accepted for Oral Presentation at 2009 Society of Nuclear Medicine Annual Meeting -- --Over 65 Recurrent GBM Patients in Phase I and Phase II Clinical Trials Have Received Cotara to Date, with a Good Safety Profile and Longer-Term Survivors Seen in All Studies-- TUSTIN, Calif., May 28 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for...

2009-04-20 11:34:51

U.S. cancer scientists say they have created an imaging technique that predicts brain tumor mortality by analyzing changes in a tumor's blood flow. The technique created by researchers at the University of Michigan Comprehensive Cancer Center uses a standard magnetic resonance imaging protocol to monitor changes over time in tumor blood volume within individual voxels -- three-dimensional analogues of pixels -- rather than a composite view of average change within the tumor. That parametric...


Word of the Day
humgruffin
  • A terrible or repulsive person.
Regarding the etymology of 'humgruffin,' the OED says (rather unhelpfully) that it's a 'made-up word.' We might guess that 'hum' comes from 'humbug' or possibly 'hum' meaning 'a disagreeable smell,' while 'gruffin' could be a combination of 'gruff' and 'griffin.'